C07D 217/26
Carbon atoms having three bonds to hetero atoms with at the most
Official title: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
C07D217/26 (Carbon atoms having three bonds to hetero atoms with at the most) appears on 723 US grants and 592 published applications in this corpus.
Search patents in C07D- Granted patents
- 723
- Published applications
- 592
- Assignees
- 381
- Inventors
- 2,207
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 7 | 0 |
| 1978 | 14 | 0 |
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 8 | 0 |
| 1982 | 3 | 0 |
| 1983 | 5 | 0 |
| 1984 | 2 | 0 |
| 1985 | 10 | 0 |
| 1986 | 12 | 0 |
| 1987 | 9 | 0 |
| 1988 | 4 | 0 |
| 1989 | 9 | 0 |
| 1990 | 7 | 0 |
| 1991 | 4 | 0 |
| 1992 | 9 | 0 |
| 1993 | 13 | 0 |
| 1994 | 9 | 0 |
| 1995 | 20 | 0 |
| 1996 | 34 | 0 |
| 1997 | 30 | 0 |
| 1998 | 22 | 0 |
| 1999 | 29 | 0 |
| 2000 | 16 | 0 |
| 2001 | 20 | 5 |
| 2002 | 29 | 26 |
| 2003 | 26 | 33 |
| 2004 | 20 | 36 |
| 2005 | 11 | 28 |
| 2006 | 20 | 28 |
| 2007 | 21 | 26 |
| 2008 | 21 | 27 |
| 2009 | 15 | 19 |
| 2010 | 16 | 29 |
| 2011 | 19 | 16 |
| 2012 | 14 | 25 |
| 2013 | 18 | 19 |
| 2014 | 17 | 38 |
| 2015 | 33 | 47 |
| 2016 | 25 | 29 |
| 2017 | 24 | 23 |
| 2018 | 18 | 10 |
| 2019 | 9 | 18 |
| 2020 | 10 | 18 |
| 2021 | 10 | 11 |
| 2022 | 13 | 20 |
| 2023 | 8 | 23 |
| 2024 | 5 | 11 |
| 2025 | 10 | 18 |
| 2026 | 8 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Fused ring compound and application thereof28 Jul 2026US 12,692,235 B2Wuhan Ll Science and Technology Development Co., Ltd.
- HDAC6 inhibitors and uses thereof16 Jun 2026US 12,655,106 B2Eikonizo Therapeutics, Inc.
- USP30 inhibitors and uses thereof2 Jun 2026US 12,643,852 B2Vincere Biosciences, Inc.
- Isoquinoline derivatives as SIK2 inhibitors26 May 2026US 12,637,428 B2Cancer Research Technology Limited
- Preparation method for (R)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid, derivatives thereof and levo-praziquantel28 Apr 2026US 12,612,398 B2Tongli Biomedical Co., Ltd.
- Bicyclic compounds8 Oct 2026US 2026/0308114 A1Vivace Therapeutics, Inc.
- Usp30 inhibitors and uses thereof1 Oct 2026US 2026/0297026 A1Vincere Biosciences, Inc.
- Therapy based on synthetic lethality in swi/snf complex-dysfunction cancer27 Aug 2026US 2026/0248806 A1National Cancer Center
- Isoquinoline derivatives as protein degraders, e7 degraders, antivirals, tumor therapeutics and immune suppressives4 Jun 2026US 2026/0151384 A1Rdp Pharma AG
- Methods for treating cancer14 May 2026US 2026/0130925 A1Genesis Molecular AI, Inc.
Most cited
By later US patents
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals122US 6,093,730 AHoechst Marion Roussel Deutschland GmbH · 2000
- HIV protease inhibitors useful for the treatment of AIDS118US 5,413,999 AMerck & Co., Inc. · 1995
- Modulators of ATP-binding cassette transporters118US 7,598,412 B2Vertex Pharmaceuticals Incorporated · 2009
- Isoquinoline compounds having antiinfective activity117US 6,777,425 B2GeneSoft Pharmaceuticals, Inc. · 2004